Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Semaglutide the original ~14.9% average body-weight reduction at 52 weeks Targets GLP-1 (one pathway) Weekly injection Best for: first-timers, or anyone sensitive to side effects Tirzepatide the upgrade ~22.1% average body-weight reduction at 52 weeks Targets GLP-1 + GIP (two pathways) Weekly injection Best for: plateaued on semaglutide, or want stronger results Retatrutide the newest ~25.9% average body-weight reduction at 52 weeks Targets GLP-1 + GIP + glucagon (three pathways) Weekly injection Best for: want the newest science, comfortable with a compounded option Semaglutide: the original Semaglutide is a GLP-1 receptor agonist
Glutathione is one of the most abundant and potent intracellular antioxidants
BPC-157 peptide therapy injections reach the bloodstream fastest, but the form that is right for you might depend on your presenting clinical issue
Diabetes Care (2022)
It's hardly shocking so many of us are interested in the drug, seeing as countless celebrities have been candid about how it's helped transform their lives and bodies
US$ 22.33
US$ 28.40
US$ 22.16
US$ 26.46
US$ 29.87
US$ 27.80
